These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2651137)

  • 1. Anticonvulsant effects of MK-801 and glycine on hippocampal afterdischarge.
    Peterson SL; Boehnke LE
    Exp Neurol; 1989 May; 104(2):113-7. PubMed ID: 2651137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The drug MK-801 attenuates the development, but not the expression, of long-term potentiation and stimulus train-induced bursting in hippocampal slices.
    Swartzwelder HS; Ferrari C; Anderson WW; Wilson WA
    Neuropharmacology; 1989 May; 28(5):441-5. PubMed ID: 2657480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a noncompetitive antagonist (MK-801) of NMDA receptors on convulsions and brain amino acid level in E1 mice.
    Sato K; Morimoto K; Hiramatsu M; Mori A; Otsuki S
    Neurochem Res; 1989 Aug; 14(8):741-4. PubMed ID: 2554174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory influence of excitatory amino acid antagonists on penicillin-induced epileptiform bursting in rat hippocampal slices.
    Sagratella S; Frank C; de Carolis AS
    Pharmacol Biochem Behav; 1990 Apr; 35(4):999-1001. PubMed ID: 2189145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unilateral intrahippocampal injection of MK-801 upon local cerebral glucose utilisation in conscious rats.
    Kurumaji A; McCulloch J
    Brain Res; 1990 Jun; 518(1-2):342-6. PubMed ID: 2202490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of various GABA receptor agonists and glutamate antagonists on focal hippocampal seizures in freely moving rats elicited by low-frequency stimulation.
    Katsumori H; Minabe Y; Osawa M; Ashby CR
    Synapse; 1998 Jan; 28(1):103-9. PubMed ID: 9414023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of intra-hippocampal injection of TRH in amygdala kindled rats.
    Wan RQ; Noguera EC; Weiss SR
    Neuroreport; 1998 Mar; 9(4):677-82. PubMed ID: 9559937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice.
    Kass IS; Chambers G; Cottrell JE
    Exp Neurol; 1989 Feb; 103(2):116-22. PubMed ID: 2563246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.
    Mintz M; Rose IC; Herberg LJ
    Pharmacol Biochem Behav; 1990 Apr; 35(4):815-21. PubMed ID: 2161108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the benzodiazepine receptor antagonist Ro 15-1788 on the anticonvulsant and anticonflict actions of MK-801.
    Clineschmidt BV
    Eur J Pharmacol; 1982 Oct; 84(1-2):119-21. PubMed ID: 6814930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.
    Ormandy GC; Jope RS; Snead OC
    Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Ticku MK
    Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
    Gilbert ME; Mack CM
    Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
    Wlaź P; Baran H; Löscher W
    Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.